| 9517207 |
Pharmaceutical formulation containing gelling agent |
Benjamin Oshlack, Christopher Breder |
2016-12-13 |
| 9456989 |
Tamper-resistant oral opioid agonist formulations |
Benjamin Oshlack, J. David Haddox |
2016-10-04 |
| 9387173 |
Pharmaceutical formulation containing gelling agent |
Benjamin Oshlack, Christopher Breder |
2016-07-12 |
| 9387174 |
Pharmaceutical formulation containing gelling agent |
Benjamin Oshlack, Christopher Breder |
2016-07-12 |
| 9326959 |
Opioid dosage forms having dose proportional steady state Cave and AUC and less than dose proportional single dose Cmax |
Robert D. Colucci, Ahmed El-Tahtawy |
2016-05-03 |
| 9308171 |
Pharmaceutical formulation containing gelling agent |
Benjamin Oshlack, Christopher Breder |
2016-04-12 |
| 9308170 |
Pharmaceutical formulation containing gelling agent |
Benjamin Oshlack, Christopher Breder |
2016-04-12 |
| 9289397 |
Titratable dosage transdermal delivery system |
— |
2016-03-22 |
| 9278073 |
Tamper-resistant oral opioid agonist formulations |
Benjamin Oshlack, J. David Haddox |
2016-03-08 |